Contact

What are you looking for?

Japan Designates PFOA isomers and PFOA-related compounds as Class I Specified Substances

SafeGuardSAutomotive, Electrical & Electronics, Hardgoods, Personal and Protective Equipment, Softlines, Toys and Juvenile ProductsJuly 16, 2024

SG 113/24

Japan has added PFOA isomers, their salts and PFOA-related compounds as part of the nation’s management program on Class I Specified Substances. With a few exceptions, many of the provisions in the new cabinet order will apply from January 10, 2025.

On July 10, 2024, Japan issued Cabinet Order No. 244 in the nation’s Official Journal (time limited for free viewing) to amend the nation’s Enforcement Order of the Act on the Examination of Chemical Substances and Regulation of Their Manufacturing, etc. (Cabinet Order No. 202 of 1974) by designating perfluorooctanoic acid (PFOA) isomers or its salts and PFOA-related compounds as Class I Specified Chemical Substances.

Unless authorized/permitted, the manufacture, import and use of a Class I Specified Chemical Substance is, in principle, prohibited, and the import of products containing such a substance is also banned (see SafeGuardS 54/24 for a guidance document in English covering products that cannot be imported if they contain Class I Specified Chemical substances)

Cabinet Order No. 244 contains several important provisions. It:

  • Expands entry 34 for ‘PFOA or its salts’ to include ‘PFOA isomers’ as Class I Specified Chemical Substances (the phrase ‘PFOA or its salts’ is consistently replaced with ‘PFOA or its isomers, or their salts’ in the regulatory text)

  • Replaces existing entry 35 (PFHxS, now under entry 36) with PFOA-related compounds as Class I Specified Substances, defined as perfluorooctyl iodide (PFOI), 8:2 fluorotelomer alcohol (8:2 FTOH) and substances that degrade to PFOA as specified by the Ministry of Health, Labor and Welfare (MHLW) and other competent authorities

  • Prohibits the importation of several categories of products if these contain PFOA-related compounds (see Table 1 below)

  • Provides the following transitional measures:
    • 8:2 FTOH may be used for the manufacture of invasive and implantable medical devices until December 3, 2025
    • PFOI may be used in the manufacture of perfluorooctyl bromide (PFOB) for pharmaceutical products until December 31, 2036

PFOA-related compounds may, subject to permission, be used in fire extinguishers, fire extinguishing agents for fire extinguishers and fire extinguishing foams


Substance
Products prohibited from import
Effective date
PFOA-related compounds
  • Antifoaming agents
  • Clothing treated with oil- or water repellent properties
  • Fabrics treated with oil- or water-repellent properties
  • Fire extinguishers, fire extinguishing agents for fire extinguishers, and fire extinguishing foams
  • Floor coverings treated with oil- or water-repellent properties
  • Floor wax
  • Oil-repellent, water-repellent and antifouling agents and fiber protecting agents
  • Optical fibers or coating agents applied to optical fiber
January 10, 2025

Table 1

With the exception of a few provisions, Cabinet Order No. 244 will become effective on January 10, 2025 – six months after the date of promulgation.

Further information on the amendment can be found on the Ministry of Economy, Trade and Industry website.

With an extensive global network of highly experienced technicians and local state-of-the-art laboratories, SGS’s Restricted Substance Testing Service (RSTS) is a one-stop solution for manufacturers and suppliers. Discover more on our website, visit our RSTS cloud, or contact us if you would like to learn more about how SGS can support. In the end, it’s only trusted because it’s tested.

© SGS Société Générale de Surveillance SA. This publication or website is a property of SGS Société Générale de Surveillance SA. All contents including website designs, text, and graphics contained herein are owned by or licensed to SGS Société Générale de Surveillance SA. The information provided is for technical and general information purposes only and offers no legal advice. The information is no substitute for professional legal advice to ensure compliance with the applicable laws and regulations. All information is provided in good faith “as is”, and SGS Société Générale de Surveillance SA makes no representation or warranty of any kind, express or implied, and does not warrant that the information will be error-free or meet any particular criteria of performance or quality.

For further information, please contact:

HingWo Tsang

Dr.

Hingwo

Tsang

Global Information and Innovation Manager

Stay on top of regulatory changes within your industry

Digital cart concept

News & Insights

  • SGS Headquarters

1 Place des Alpes,

P.O. Box 2152,

1211, Geneva, Switzerland